Scopus Indexed Publications

Paper Details


Title
FDA approved vaccines for monkeypox: Current eminence
Author
, Talha Bin Emran,
Email
Abstract

Monkeypox is caused by the monkeypox virus, a member of the Orthopoxvirus genus in the family Poxviridae. It was declared a global public health emergency by the World Health Organization (WHO) on June 23, 2022 [1]. Monkeypox is usually a self-limiting illness, with symptoms lasting anywhere from two to four weeks. Fever, headache, muscular pains, back discomfort, fatigue, and enlarged lymph nodes are the most typical symptoms. A two-to three-week-long rash may follow or accompany these symptoms. Rashes may appear on the face or body parts such as palms/feet/soles of feet or eyes/mouth/throat/groin/anal areas. There might be as few as one or as many as several thousand lesions. Before the lesions fall off and a new layer of skin grows on top of the old one, lesions are flat and liquid-filled before they become crusted and dry. Difficult situations may happen. The case fatality rate has been hovering around 3–6% recently.


Keywords
Journal or Conference Name
International Journal of Surgery (Letter)
Publication Year
2022
Indexing
scopus